Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease

NCT07150338 · clinicaltrials.gov ↗

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease (Stage 3-4)
Chronic Kidney Disease (Stages 4 and 5)
Proteinuria

Interventions

DRUG: QRX-3
DRUG: Eseronate

Sponsor

Neukidney Inc.